Celltrion Healthcare gets the OK to list
Celltrion Healthcare, the marketing affiliate of Korean drug manufacturer Celltrion, has got the go ahead from Korea Exchange to launch its IPO, which could raise up W1tr ($873.4m) according to a source familiar with the matter.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: